期刊文献+

PAP和PSA与前列腺癌诊治的关系 被引量:5

PAP PSA and the diagnosis of prostate cancer
暂未订购
导出
摘要 目的 :探讨前列腺酸性磷酸酶 (PAP)、前列腺特异抗原 (PSA)与前列腺癌的诊断、临床分期、预后判断的关系。方法 :用放射免疫测定法 (RIA)检测经病理检查证实的前列腺癌 5 2例 ,同时以 PAP、PSA辅助诊断。结果 :PSA阳性率明显高于直肠指检、B超和 PAP(P <0 .0 5 )。PAP和 PSA升高与前列腺癌的分期、肿瘤细胞分化程度具有相关性。结论 :PAP和 PSA对前列腺癌的诊断、临床分期。 Purpose:To study the relationship between PAP,PSA and prostatic cancer′s diagnosis,clinic stage and prognosis.Method:RIA was employed in testing 52 cases of prostate cancer,which had been proved by pathological examination,PAP and PSA was used in the diagnosis.Result:Postive PSA rate is evidently higher than DRE,B ultrasonography and serum PAP (P< 0.05 ).The percentage of patients with rising PAP and PSA is correlated to the stage of prostatic cancer and the differentiation of neoplastic cells.Conclusion:PAP and PSA is of great value to the diagnosis of prostate cancer,the clinic stage and prognosis
出处 《临床泌尿外科杂志》 2001年第11期471-473,共3页 Journal of Clinical Urology
关键词 前列腺肿瘤 前列腺酸性磷酸酶 前列腺特异抗原 PAP PSA Prostatic neoplasms Prostatic acid phosphatase Prostate specific antigon
  • 相关文献

参考文献6

  • 1顾方六.泌尿外科专业四十年来的回顾与进展[J].中华外科杂志,1991,29(1):37-40. 被引量:3
  • 2徐耀庭,陈修诚,刘纯.前列腺特异性抗原和前列腺酸性磷酸酶的临床应用价值比较[J].临床泌尿外科杂志,1994,9(3):147-149. 被引量:5
  • 3Buamah P K, Johnson P, Skillne A W, et al. Comparative study of the clinical usefuless of prostatespecific antigen and prostatic acid phoshpatase in prostatic disease. Br J Urol, 1988,62: 581 - 583.
  • 4Catalona W J,Smith D S,Ratliff T L. Measurement of prostate-specific antigen in serum as a screning test for prostate cance. N Engl J Med,1991,324:1156-1161.
  • 5Lange P H. Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery. Urol Clin Nor Am, 1990,17: 813 - 817.
  • 6Stamey T A ,Kabalin J N ,Mcneal J E. Prostate-specific antigen in the diagnosis and treatment of adenocarcino ma of the prostate. J Urol, 1989, 141: 1088-1090.

共引文献6

同被引文献30

  • 1邓晓洪,杜文华,欧平,王元中,郑军,王翔.血清PSA测定结合超声引导下经直肠前列腺穿刺活检诊断前列腺癌[J].临床超声医学杂志,2006,8(4):213-215. 被引量:5
  • 2孙凤岭,臧桐,郭应禄.前列腺癌研究的新亮点-雌激素β受体[J].国际泌尿系统杂志,2006,26(5):630-632. 被引量:1
  • 3肖丽萍,毕向军,李亚南,陈晓清,张晓峰,余新沛,刘岗,杨明常,宋骤.前列腺特异性抗原对前列腺癌早期诊断的价值[J].南方医科大学学报,2007,27(1):107-108. 被引量:10
  • 4邵远 张祖豹.前列腺PSA、PSAD与癌结节的关系[J].中华肿瘤杂志,2000,1(22):118-120.
  • 5Shin Egawa, Shigehiro Soh, Makoto Ohori, et al, The ratio of free to total serum prostate specific antigen and its use in differential diagnosis or prostate carcinoma in Japan. Cancer, 1997,79:90-98.
  • 6Wang MC, Valeuzula La, Murphy Gp, et al. Purification of a human prostate specific antigen. Invest Urol, 1979,17:159-163.
  • 7Arai Y, Yoshiki T,Okada KL, et al. Multiple marker evaluation in prostatic cancer using prostatic specific antigen , gammaseminoprotein and prostatic acid phosphatase. Urol Int, 1989,44 :135.
  • 8Dupont A, Cusan L, Gomez JL, et al. Prostate specific antigen and prostatic acid phosphtase for monitoring therapy of carcinoma of the prostate. J Urol, 1991,146T1064.
  • 9Arai Y, Yoshiki T,Okada KL, et al. Multiple marker evaluation in prostatic cancer using prostatic specific antigen , gamma-seminoprotein and prostatic acid phosphatase.Urol Int, 1989,44:135.
  • 10Dupont A, Cusan L, Gomez JL, et al. Prostate specific antigen and prostatic acid phosphtase for monitoring therapy of carcinoma of the prostate.J Urol, 1991,146:1064.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部